Project Details
Description
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
| Status | Finished |
|---|---|
| Effective start/end date | 7/7/23 → 6/30/25 |
Funding
- CHILDREN'S HOSPITALS & CLINICS OF MN
- NIH NATIONAL CANCER INSTITUTE
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.